Harry Sherman

Harry Sherman is a highly experienced scientific lead at Helios Medical Communications since February 2023, with a robust background in medical writing and communications developed at Lucid Group from November 2018 to February 2023. Harry's experience spans multiple roles including senior medical writer and associate medical writer, with exposure to various therapy areas and a strong understanding of compliance regulations in medical communications. Harry completed a Doctor of Philosophy in Advanced Therapeutics and Nanomedicines at the University of Nottingham, where research focused on electron transport systems in oncology. Previous placements include involvement in nanoparticle synthesis at the University of Nottingham and industry experience at MedImmune, enhancing skills in formulation techniques. Harry holds a Bachelor's degree in Biochemistry from the University of Nottingham and a foundational education from Maidstone Grammar School for Boys.